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httpcense.Abstract Background: In the Kingdom of Saudi Arabia, the prevalence of asthma was 12%, with
vast regional variations ranging from less than 10% in Dammam to 23% in Hail. Makka city has a
lot of mountains that under the process of breaking causes dusty environment. So, the aim of this
study was to evaluate the inﬂuence of broken mountain dusty environment on bronchial asthma
patients in Makka city.
Subjects and methods: The study included 50 male patients of bronchial asthma in 2 groups.
Group (A); 25 bronchial asthma patients were not exposed to broken mountains, and group (B)
25 bronchial asthma patients were exposed to broken mountains. All patients were matched as
regards age. Pulmonary function parameters [PEFR%, FEV1%, reversibility), skin prick test,
immunoglobulin-E (IgE) and sputum levels of matrix metalloproteinase-9 and matrix metallopro-
teinase-9/tissue inhibitor of matrix metalloproteinase-1 (MMP-9 and MMP-9/TIMP-1) were mea-
sured. All patients received anti-asthmatic therapy (inhaled long acting B2-against and inhaled
corticosteroid and theophylline) for one month then re-assess the condition as regards, asthmatic
symptoms, pulmonary function parameters, and need for reliever. The patients were categorized
as controlled, partially controlled and non-controlled.
Results: Group B was more worsening as regards, duration of symptoms, limitations of activi-
ties, awakening and need for more reliever. Also, group B was more worsening as regards pulmon-
ary function parameters (PEFR%, FEV1%, reversibility). Group B was more atopic with higher
matrix metalloproteinase-9 and ratio of matrix metalloproteinase-9/tissue inhibitor of matrix
metalloproteinase-1. Lastly group B was worst than group A as regards controlling the attacks96450083.
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Conclusion: Bronchial asthma patients in Makka city who were exposed to dusty environment
due to broken mountains were more worsen clinically, functionally and as response to anti-asth-
matic therapy than the other group who were not exposed to dusty environment.
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B.V.Open access under CC BY-NC-ND license.Introduction
Asthma is a common condition that affects 5–10% of the pop-
ulation worldwide [1]. In the kingdom of Saudi Arabia, the
prevalence of asthma was‘12%, with vast regional variations
ranging from less than 10% in Dammam to 23% in Hail [2].
Makka city has a lot of mountains that under the process of
breaking causes dusty environment.
It is widely accepted that there is an increase in morbidity
and mortality due to bronchial asthma [3]. This may be attrib-
uted to environmental and social changes such as rapid urban-
ization, increased exposure to indoor allergens and
occupational exposure [4].
So, the aim of this study was to evaluate the inﬂuence of
broken mountain dusty environment on bronchial asthma pa-
tients in Makka city.
Materials and methods
This study included 50 bronchial asthma patients (GINA 2010
guidelines) [5]. They were selected from the allergy and immu-
nology outpatient clinic of Makka-Hospital in Makka city-
Saudi Arabia in the duration from January 2011 to February
2012.
They are divided into 2 groups (group A and group B)
matched as regards age and all patients were males. Each
group had 25 patients, group A was not exposed to broken
mountain but, group B was working in broken mountain.
All participants were subjected to the following after writ-
ten consents:
1. Full medical history and clinical examination.
2. Pulmonary function tests:
 Peak expiratory ﬂow rate (PEFR) using traditional peak
ﬂow meter expressed as percentage of the predicted values
considering the height, age and sex.
 Forced expiratory volume in one second (FEV1) and the
results expressed as percentage of the predicted values.
 Reversibility test by using short acting B2-agonist.
3. Skin prick test:
 Using standard allergen extracts (house dust, mixed pollens,
mite, mold and grass), negative control (saline) and positive
control (histamine).
4. Sputum induction for:
 Measurement of both MMP-9 and TIMP-1 (by ELISA
technique from oncogene TM research products, sandwich
enzyme) results was expressed in ng/ml [6].
 Sputum induction:
 According to Kanazawa [7] and his colleagues patients were
premedicated with inhaled salbutamol, after washing their
mouths, they inhale normal saline by nebulizer and encour-
aged to cough deeply after 5 and 10 min into polypropylene
containers.5. Serum total immunoglobulin E (IgE) in IU/L by ELISA
Quantitative measurement was performed by a commer-
cially available ELISA kit (Med Biotech. Inc. Agenzme Com-
pany, Industrial Road, San carlos, CA, USA). Then all
patients received anti-asthmatic therapy (inhaled B2-agonist
LABA, inhaled corticosteroids and theophylline) for one
month, then reassess the condition as regards, symptoms,
PEFR%, FEV1%, and reversibility and need for reliever.
The patients were categorized as controlled, partially con-
trolled and non-controlled according to GINA 2010 guideline
[5].
Statistical analysis
Data were checked, entered and analyzed by using SPSS ver-
sion 20. Data were expressed as mean ± SD for quantitative
variable, number and percentage for categorical variable.
Chi-squared (X2) or Fisher’s extract test and t-test were used
when appropriate. P< 0.05 was considered statistically
signiﬁcant.
Results
Table 1 shows non signiﬁcant difference between group A and
B as regards age of the patients (P value = 0.75) but, group B
is more worse than group A as regards frequency of symptoms,
limitations of activities, awakening and need for more therapy
as reliever.
Table 2 shows signiﬁcant difference between group A and B
as regards pulmonary function tests (PEFR, %pred. and
reversibility) whereas group B is more worse than group A
(P< 0.001 and 0.05).
Table 3 shows that group B has more increase in IgE level
than group A. Also, the result for the skin prike test is more
atopic in group B (P< 0.001 for both).
Table 4 shows that MMP-9 level in sputum is more in
group B and MMP-9/TIMP-1 ratio is more in group B indicat-
ing more inﬂammation and remodeling.
Table 5 shows that group B is worse as regards controlling
the attacks of bronchial asthma using anti-asthmatic therapy
for one month (controlled 9 (36%) in group B versus 16
(64%) in group A).
Discussion
Asthma is a common chronic disorder of the airways, charac-
terized by variable reversible and recurring symptoms related
to airﬂow obstruction, bronchial hyperresponsiveness and an
underlying inﬂammation. It is one of the most common
chronic diseases in Saudi Arabia, affecting more than 2 million
Saudis (GINA, 2010) [5].
Table 2 Pulmonary function tests among studied groups.
PF tests Group A 25 Group B 25 P-value
PEFR% pred. mean ± SD 78.9 ± 7.2 61.4 ± 6.7 <0.001**
FEV1% pred. mean ± SD 75.7 ± 9.8 60.8 ± 7.9 <0.001
**
Reversibility test 20.0 ± 2.9 18.2 ± 2.8 0.03*
* Signiﬁcant.
** Highly signiﬁcant.
Table 4 Matrix metalloproteinase-9 and matrix metallopro-
teinase-9/tissue inhibitor of matrix metalloproteinase-1 among
studied groups.
Metalloproteinase
in sputum
Group A25 Group B25 P-value
MMP-9 (ng/ml) 162 ± 83.2 322 ± 95.1 <0.001**
TIMP (ng/ml) 291 ± 115 340 ± 10.2 0.11 (NS)
Ratio 0.56 ± 0.17 0.94 ± 0.19 <0.001**
** Highly signiﬁcant. NS: Non-signiﬁcant.
Table 5 The response to anti-asthmatic therapy for one
month in studied groups.
Group A25 Group B25 P-value
Controlling 16 (64.0%) 9 (36.0%) 0.04*
Partially 5 (24.0%) 6 (24.0%) 1.0 (NS)
Non-controlled 4 (12.0%) 10 (40.0%) 0.024*
* Signiﬁcant. NS: Non-signiﬁcant.
Table 1 Age and clinical data among studied groups.
Group A 25 Group B 25 P-value
Age 32.6 ± 8.4 32.9 ± 7.3 NS
Frequency of symptoms per week
62 20 (80.0%) 9 (36.0%) 0.0016*
>2 5 (20%) 16 (64%)
Limitations of activities
None 23 (92.0%) 10 (40%) <0.001**
Any 2 (8.0%) 15 (60%)
Awakening
Non 22 (88.0%) 8 (32.0%) <0.001**
Any 3 (12.0%) 17 (68.0%)
Need for reliever per week
62 19 (76.0%) 10 (40.0%) 0.009*
> 2 6 (24.0%) 15 (60.0%)
* Signiﬁcant.
** Highly signiﬁcant. NS: Non-signiﬁcant.
Table 3 Immunoglobulin E (IgE) and skin prike test among
studied groups.
Group A25 Group B25 P-value
IgE 465 ± 25.5 830 ± 38.2 <0.001**
Skin prike test
Atopic 11 (44.0%) 23 (92.0%) <0.001**
Non-atopic 14 (56.0%) 2 (8.0%)
** Highly signiﬁcant.
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dust in areas of broken mountain like, Makka leads to more
prevalence of allergic symptoms. A recent asthma control sur-
vey showed that only 5% were controlled, 31% were partially
controlled and 64% were uncontrolled [8].
So, we designed this study to clarify the inﬂuence of broken
mountain on bronchial asthma patients in Makka.
In the current study, group B is more worse than group A
as regards, duration of symptoms, limitations of activities,
awakening and need for more therapy (reliever).
This result is concomitant with Abdulaziz Al-Mazam and
Ashry G. Mohamed (2001) [9] who found that patients having
bronchial asthma are more worse if located near a brick fac-
tory with exposure to air-pollution (living near these factories
61 km). These results can be explained by the exposure to bro-
ken mountain not only expose the patients to dust but also, to
induce the mountain explosions and dynamite bomb. These
will lead to get out excess gases like SO2, NO2, CO2 and CO
particles that induce several inﬂammatory mechanisms in the
airways. These include damage to airway epithelium, induced
changes in lung function and enhanced release of inﬂammatory
mediators [10].
Also, group B has more increase in IgE level than group A
and also, the result of the skin prike test is more atopic in
group B.
This result is in concomitant with Lundback [11] who told
that the atopic patients have increased risk of asthma severity
when exposed to air-pollutions.
Also El-Gamal et al. [8] reported independent association
between personnel history of allergy and bronchial asthma.
The result in the current study can be explained by
group B was more atopic in 23 (92%) positive skin-prick
test with higher, IgE. So, when exposed to air-pollution
like dust and various gases patients became more
worsening.
Matrix metalloproteinase-9 (MMP-9) level in sputum of
group B is higher than in group A and the ratio of MMP-9/
TIM-1 (matrix metalloproteinase-9/tissue inhibitor of matrix
metalloproteinase-1) is more higher in group B than group A
indicating more inﬂammation and remodeling of the airways
in group B.
This result is in concomitant with Ghada Mahmoud
Mohamed et al. [12] which reported that MMP-9 and TIMP-
1 play an important role in pathophysiology of asthma exacer-
bation and airway remodeling.
Also, group B is worst than group A as regards controlling
the bronchial asthma attacks using anti-asthmatic therapy (9
cases versus 16 cases).
These can be explained by the exposure of group B to air-
pollution like dust and various gases during the process of bro-
ken mountain triggering a more inﬂammation and remodeling
of the airways with less response to therapy.Conclusion
Bronchial asthma patients in Makka city who were exposed to
dusty environment due to broken mountains were more wor-
sen clinically, functionally and as response to anti-asthmatic
therapy than other group who were not exposed to dusty
environment.
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